Analysts expect Westell Technologies, Inc. (NASDAQ:WSTL) to report $0.03 EPS on February, 14.WSTL’s profit would be $466,945 giving it 25.83 P/E if the $0.03 EPS is correct. After having $0.09 EPS previously, Westell Technologies, Inc.’s analysts see -66.67% EPS growth. The stock increased 3.33% or $0.1 during the last trading session, reaching $3.1. About 33,417 shares traded. Westell Technologies, Inc. (NASDAQ:WSTL) has declined 30.72% since February 8, 2017 and is downtrending. It has underperformed by 47.42% the S&P500.
Abbott Labs (NYSE:ABT) had a decrease of 6.84% in short interest. ABT’s SI was 12.45M shares in February as released by FINRA. Its down 6.84% from 13.37 million shares previously. With 5.59 million avg volume, 2 days are for Abbott Labs (NYSE:ABT)’s short sellers to cover ABT’s short positions. The SI to Abbott Labs’s float is 0.73%. The stock increased 0.31% or $0.18 during the last trading session, reaching $59.04. About 6.87M shares traded or 0.98% up from the average. Abbott Laboratories (NYSE:ABT) has risen 15.90% since February 8, 2017 and is uptrending. It has underperformed by 0.80% the S&P500.
Among 2 analysts covering Westell Technologies (NASDAQ:WSTL), 1 have Buy rating, 1 Sell and 0 Hold. Therefore 50% are positive. Westell Technologies had 4 analyst reports since September 2, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Monday, September 28 by Northland Capital. The firm earned “Buy” rating on Friday, November 3 by Northland Capital. The firm earned “Sell” rating on Wednesday, September 2 by Zacks. The stock of Westell Technologies, Inc. (NASDAQ:WSTL) has “Buy” rating given on Friday, August 11 by Northland Capital.
Westell Technologies, Inc., through its subsidiary, Westell, Inc., creates and distributes telecommunications products to telephone companies in the United States. The company has market cap of $48.25 million. The firm operates through three divisions: In-Building Wireless , Intelligent Site Management and Services (ISMS), and Communications Network Solutions (CNS). It currently has negative earnings. The IBW segment offers distributed antenna systems conditioners; repeaters; battery backup units; and system components and antennas, including couplers, duplexers, splitters, filters, and tappers for commercial and public safety in-building wireless systems.
Since August 16, 2017, it had 0 buys, and 8 sales for $41.44 million activity. Salvadori Daniel Gesua Sive had sold 62,460 shares worth $3.31M. $2.69 million worth of Abbott Laboratories (NYSE:ABT) was sold by Ford Robert B. Another trade for 52,700 shares valued at $2.74 million was made by Contreras Jaime on Friday, September 22. Fussell Stephen R also sold $14.27 million worth of Abbott Laboratories (NYSE:ABT) shares. Blaser Brian J sold $1.73M worth of stock or 27,733 shares.
Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 105 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Citigroup given on Tuesday, January 30. The stock of Abbott Laboratories (NYSE:ABT) has “Overweight” rating given on Wednesday, October 7 by Barclays Capital. The firm has “Market Perform” rating given on Friday, January 29 by William Blair. The firm has “Buy” rating given on Thursday, August 4 by Jefferies. BTIG Research reinitiated Abbott Laboratories (NYSE:ABT) rating on Wednesday, June 21. BTIG Research has “Buy” rating and $56 target. Argus Research upgraded the stock to “Buy” rating in Friday, February 5 report. The firm has “Buy” rating given on Saturday, August 29 by BTIG Research. The firm has “Buy” rating given on Thursday, October 19 by Stifel Nicolaus. The rating was upgraded by William Blair to “Buy” on Thursday, January 25. Jefferies maintained the stock with “Buy” rating in Friday, June 16 report.